# Liposomal Bupivacaine Versus Plain Bupivacaine After Intercostal Injections For Pain Management After Thoracoscopy

> **NCT03737292** · PHASE4 · RECRUITING · sponsor: **Milton S. Hershey Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Pain, Postoperative
- Pharmacokinetics

## Interventions

- **DRUG:** Exparel
- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT03737292
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-04-09
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03737292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03737292, "Liposomal Bupivacaine Versus Plain Bupivacaine After Intercostal Injections For Pain Management After Thoracoscopy". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT03737292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*